GESYNTA PHARMA
Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study, GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positi... ve results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
GESYNTA PHARMA
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.gesynta.se
Total Employee:
1+
Status:
Active
Contact:
559103-6628
Email Addresses:
[email protected]
Total Funding:
27.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Closed Loop Medicine
Developing personalised digital healthcare solutions to improve outcomes for patients and clinicians
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
Synapse Medicine
Synapse Medicine offers a medication intelligence platform for healthcare professionals.
Current Employees Featured
Founder
Investors List
Hadean Ventures
Hadean Ventures investment in Series C - Gesynta Pharma
Industrifonden
Industrifonden investment in Series C - Gesynta Pharma
Linc AB
Linc AB investment in Series C - Gesynta Pharma
Industrifonden
Industrifonden investment in Seed Round - Gesynta Pharma
Official Site Inspections
http://www.gesynta.se
- Host name: solnabergproperty.se
- IP address: 81.170.239.161
- Location: Stockholm Sweden
- Latitude: 59.3307
- Longitude: 18.0718
- Timezone: Europe/Stockholm
- Postal: 110 57
